Orthopaedic Surgery

Case Western Reserve University/University Hospitals Cleveland Medical Center Program

Cleveland, OH · East North Central

🌍 J-1 VisaCategoricalResearchAcademic/Clinician Educator
YOUR FIT· Case Western Reserve University/University Hospitals Cleveland Medical Center Program

Create a free profile to see your personalized fit

Get Started

Contact

CH
Program Director
Christina Hardesty, MD, BA
Email director
KS
Program Coordinator
Kerwin Samson
Email coordinator

Training Sites

4 hospitals in Cleveland

  • 1
    Case Western Reserve University/University Hospitals Cleveland Medical Center
    Cleveland, OH
    Primary
  • 2
    The MetroHealth System/Case Western Reserve University
    Cleveland, OH
    Participant
  • 3
    Louis Stokes Cleveland VA Medical Center
    Cleveland, OH
    Participant
  • 4
    Ahuja Medical Center
    Beachwood, OH
    Participant

Score Ranges

USMLE Step 2 CK242272
180205230255280

Level 2 CE data not available

Interview Rates

US MD
18%
US DO
4%
US IMG
4%
Non-US IMG
0%

Applicant Origin

In-State
36%
Out-of-State
11%

Interview Prep

Common questions for Orthopaedic Surgery interviews

specialtyWhy orthopaedics over general surgery?★ common
clinicalDescribe an orthopaedic case that was memorable to you.★ common
specialtyWhat subspecialty are you considering? (Sports, spine, trauma, hand, joints)★ common
behavioralHow do you maintain work-life balance in a surgical specialty?
clinicalTell me about your surgical experience.★ common
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common

Community Resources

Orthopaedic Surgery applicant community for 2025-2026 cycle

Calculate your match probability for Orthopaedic Surgery

See how your profile compares across all programs

Open Calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.